About Niquitin
NiQuitin is a leading nicotine replacement therapy (NRT) brand now owned by Perrigo, the world's largest manufacturer of over-the-counter pharmaceutical products for the store brand market. Originally part of GSK's healthcare portfolio, NiQuitin was acquired by Perrigo and now forms a key component of their healthy lifestyle products division. Perrigo's heritage in healthcare dates back to 1887, when the company began as a packager of generic home remedies before growing into a global OTC pharmaceutical leader. The NiQuitin product range offers comprehensive support for smokers looking to quit, providing multiple formats to suit different preferences and lifestyles. The NiQuitin Clear patch system uses proprietary Smart Control Technology to deliver continuous, controlled nicotine release over a full 24 hours, helping to manage cravings throughout day and night. The three-step patch programme allows gradual weaning: Step 1 patches deliver 21mg for heavy smokers, Step 2 provides 14mg as an intermediate stage, and Step 3 offers 7mg for final transition off nicotine. For those preferring oral nicotine delivery, NiQuitin lozenges provide an alternative to patches. Available in Mint and Citrus flavours, lozenges come in 2mg strength for moderate smokers (first cigarette more than 30 minutes after waking) and 4mg strength for heavier smokers (first cigarette within 30 minutes). Standard lozenges dissolve slowly for sustained release, whilst NiQuitin Minis offer smaller, more discreet lozenges that dissolve faster for convenient use during the day. The NiQuitin Pre-Quit patch represents an innovative approach, allowing smokers to start patch therapy whilst still smoking to help prepare for their quit day. Available throughout UK supermarkets including Ocado, Tesco, Asda, and Morrisons, NiQuitin provides accessible, clinically-proven smoking cessation support. The comprehensive range ensures smokers can find a format and strength combination that works for their individual quit journey.












